TP53 and metastatic melanoma: To answer this question, we first developed a PDX library of BRAF-mutant metastatic melanoma and observed a correlation between VAF and increased stability of driver mutations across the patient tumour, corresponding PDX and subsequent generations of PDXs for multiple genes (e.g., BRAF, KDR, TP53 and PTEN).